CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Free cash flow, 2025
- $142M
- YoY, 2025
- −27.7%
- 5-year CAGR
- −1.2%
- 10-year CAGR
- +46.5%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $142M | −27.7% |
| 2024 | $196M | +55.0% |
| 2023 | $127M | +5.5% |
| 2022 | $120M | −28.4% |
| 2021 | $167M | +11.1% |
| 2020 | $151M | +11.6% |
| 2019 | $135M | +17.0% |
| 2018 | $115M | +90.6% |
| 2017 | $61M | +232.6% |
| 2016 | $18M | +484.5% |
| 2015 | $3.1M | — |
| 2014 | −$28M | — |
| 2013 | −$37M | — |
| 2012 | −$36M | — |
| 2011 | −$27M | — |